Ilaria Ferlenghi

Associate Director, Head of Structural Microscopy GSK

Agenda Day 1

Technology implementation often stalls when researchers, functional

stakeholders and R&D leaders lack a shared understanding of its value,

or when evidence takes too long to emerge. As technology advances

and investment decisions become more time-sensitive, R&D teams need

to establish a clear value case, validate it with evidence and translate

productivity gains into meaningful outcomes.

• Build a value hypothesis before investing by defining the R&D challenge,

expected impact and value of the investment, not just its potential financial

return

• Secure active stakeholder commitment to strategy execution by linking

technology initiatives to measurable R&D outcomes, strategic priorities and

tangible business value, with shared measures of success and ownership

across functions

• Establish researcher trust and sustain participation by demonstrating how

individual adoption contributes to scientific outcomes and wider business

impact throughout implementation

Check out the incredible speaker line-up to see who will be joining Ilaria.

Address: IQPC Ltd, 129 Wilton Road,
London SW1V 1JZ
Telephone: +44 (0) 207 368 9484
Fax: 44 (0) 207 368 9301
Email: exchangeinfo@iqpc.com